Boeing's Regulatory Relief Doesn't Fix What the Valuation Is Hiding

I don't think the question investors should be asking about Boeing right now is whether the company has finally cooperated with regulators. The better question is whether the stock now reflects more optimism than the cash flow can support.

Boeing (NYSE: BA) closed at $239.60 today, up roughly 12% over the past five trading days. The catalyst is straightforward: the FAA announced on July 17 that it will allow Boeing to resume issuing airworthiness certificates for all 737 MAX and 787 airplanes, effective July 20. That's the last step in the production process - the document that confirms an aircraft is safe to operate. Since September 2025, the FAA and Boeing had been alternating who issued those certificates, a heavy-handed oversight model that slowed production and cost Boeing millions in efficiency. Now the FAA says eight months of parallel data showed comparable quality regardless of who signed the paper.

On top of that, the DOJ's criminal case tied to the 737 MAX crashes - which was revived after the January 2024 doorplug blowout - was dismissed in November 2025 under a $1.1 billion non-prosecution agreement. That deal included $243 million in penalties, $444.5 million for the crash-victims beneficiaries fund, and $455 million for compliance improvements. Boeing avoids a criminal conviction that could have complicated its status as a government defense contractor.

From a headline perspective, the handcuffs are coming off. But from an income investor's perspective, handcuffs or not, the business still needs to prove it can generate the cash flow to support the multiple the market is demanding.

The Valuation Gap

Here's where the math gets uncomfortable. Boeing trades at a trailing P/E of 90.6. Its price-to-book ratio sits at 31.0. Enterprise value to EBITDA is 31.7x. By comparison, Lockheed Martin trades at 21.3x earnings, Northrop Grumman at 17.5x, and RTX at 38.5x. Even RTX - which is the most generously valued of these defense peers - is less than half Boeing's multiple.

That gap isn't a commentary on quality. It's a commentary on what the market is pricing in. Boeing's stock is reflecting an assumption that production will ramp smoothly, deliveries will accelerate, and margins will compress no further. That may be the base case management is selling. But it's also a case where one more production hiccup rewinds the thesis.

And here's the thing: the production hiccups haven't fully stopped. In March of this year - five months before the FAA handed back certification authority - Boeing paused deliveries of certain 737 MAX aircraft to rework wiring abrasions caused by a machining error. The company called it routine quality control. The FAA called it nothing, because the issue was caught before delivery. But it's the kind of defect that, in the old regime, would have been the exact reason regulators took Boeing's certification authority away in the first place.

The Dividend Reality

For income investors, the dividend profile tells an equally sobering story. Boeing suspended its dividend in March 2020 amid the pandemic and MAX crisis. The common stock dividend has been restarted at $0.75 per share annually, producing a forward yield of 3.4%. That yield looks attractive in isolation - until you check the engine underneath.

Free cash flow over the trailing twelve months is negative $219 million. Boeing spent $3.8 billion on capital expenditures while generating only $3.6 billion in operating cash flow. The payout ratio reads 17.4% of trailing earnings, but that figure is propped up by the inflated P/E multiple rather than robust cash generation. The more honest read is that Boeing is barely covering its dividend from operating cash flow after capital spending.

This is not a dividend growth story. Boeing has zero consecutive years of dividend growth since restarting the payout. It has no track record of increasing the dividend through a cycle. The 3.4% yield is a restart, not a compounding engine. If you're looking for the equity yield curve sweet spot - moderate yield with strong, reliable growth - Boeing doesn't live there yet.

The Balance Sheet Is The Anchor

Total debt stands at $159.8 billion against total equity of just $6.1 billion. That's a debt-to-equity ratio of 750%. Boeing holds $7.2 billion in cash, leaving net debt of roughly $26 billion - manageable in absolute terms for a company of this scale, but the leverage relative to equity is extreme. The company was downgraded during the crisis years and is still working its way back.

In an inflation regime that runs hotter than traditional targets - and I believe that's a scenario investors need to position for, not dismiss - high-leverage companies face a double whammy. Interest costs rise with rates, and debt service eats cash flow that could otherwise go to dividends, reinvestment, or paying down obligations. Boeing's current ratio of 113.8% and quick ratio of 33.1% show it can meet near-term obligations, but there's not much margin for error.

The Macro Context Is Actually Working In Boeing's Favor

Here's where I have to give credit to the bull case. The ISM Manufacturing PMI rose to 55.6 in July - the strongest reading since May 2022. New orders came in at 56.7, accelerating from 56.0 in June. Employment returned to expansion at 52.8, the highest level since August 2022. Transportation equipment - Boeing's ISM sub-sector - was one of three of the six largest manufacturing industries to report increased new orders.

That's a leading indicator telling us manufacturing demand is firming, not fading. For a company like Boeing, which sits at the intersection of commercial aviation recovery and government defense spending, a strengthening industrial backdrop is genuinely supportive. The 737 MAX family has a backlog of more than 7,200 orders, with over 2,300 already delivered. The 737-7 just received FAA certification on August 3, clearing another variant for delivery to launch customer Southwest Airlines.

The macro tailwinds are real. The structural demand for narrow-body aircraft over the next two decades is real. The monopoly-like duopoly with Airbus on single-aisle jets gives Boeing genuine pricing power that most industrial companies don't have.

So What?

The FAA restoring certification authority and the DOJ dropping criminal charges are real milestones. They reduce regulatory overhang and should allow production to ramp with fewer bottlenecks. If Boeing can deliver on its guidance of roughly 500 737 MAX aircraft in 2026 and scale toward 50-60 per month by 2028, the revenue trajectory is compelling.

But the stock is already pricing in a flawless execution scenario at a multiple that leaves no room for the kind of production issues Boeing has proven it's still prone to. At 90x trailing earnings, you need perfect delivery schedules, margin expansion, and no new quality incidents for the valuation to hold. One more wiring defect, one more FAA directive, one more quarter of negative free cash flow, and that multiple gets tested hard.

From an income and risk/reward point of view, Boeing doesn't yet belong in the dividend-growth sleeve. The yield is there, but the compounding engine isn't - not with negative free cash flow, a balance sheet carrying $160 billion in debt, and a dividend that was only recently restarted at a fraction of its pre-crisis level. This is a turnaround stock, not an income compounder. And turnaround stocks at 90x earnings are not turnarounds you buy for the yield.

If you believe in the long-term aerospace story - and the ISM data, the order backlog, and the duopoly pricing power give you reasons to - the entry point matters. The equity yield curve approach teaches us that the best returns come from buying quality when it's out of favor, not when it's being celebrated and priced for perfection. Boeing just got celebrated. The question is whether the price reflects the reality or just the relief.

I believe Boeing can execute its way to solid profitability over the next three to five years. But I also believe the current valuation assumes that execution is guaranteed, and it's not. The balance sheet risk, the free cash flow deficit, and the dividend's fragile restart status all suggest this stock has a long way to go before it earns a place in the income-growth part of the portfolio.